Average Co-Inventor Count = 7.10
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
2. Other (4 from 832,880 patents)
3. Merck + Co., Inc. (4 from 4,770 patents)
24 patents:
1. 10759805 - Compounds that are ERK inhibitors
2. 10745377 - Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
3. 10322140 - Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists
4. 10065967 - Compounds that are ERK inhibitors
5. 9981969 - Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
6. 9975888 - Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
7. 9808473 - Preparation and use of 3-pyridyl substituted-6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
8. 9745307 - Compounds that are ERK inhibitors
9. 9701669 - Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists
10. 9556202 - Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
11. 9233979 - Compounds that are ERK inhibitors
12. 9023865 - Compounds that are ERK inhibitors
13. 9018200 - Substituted piperidinyl compounds useful as GPR119 agonists
14. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
15. 8026264 - Triazole derivatives as inhibitors of 11-β hydroxysteroid dehydrogenase-1